EarlySign Unveils Commercial Availability of AI Diabetes Risk Predictors Algorithm

"Share with your friends Submit Medial EarlySign – an Israeli health AI company has just announced the commercial availability of its first suite of machine learning-based predictive diabetes risk solutions. Expanding the company’s portfolio of clinical risk predictors, these new diabetes-focused AlgoMarkers are designed to help healthcare systems identify and engage patients at high risk for diabetes and downstream complications. EarlySign’s Pre2D algorithm solution identifies prediabetic patients at highest risk..." Lire la suite